Treatment After Irinotecan-based Frontline Therapy: Maintenance With Erbitux (in Patients wtRAS mCRC)
Clinical trial NCT02404935 · COMPLETED
Trial details
- NCT number
- NCT02404935
- Sponsor
- UNICANCER
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-22
- Primary completion
- 2020-11-01
- Enrollment
- 139
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.